Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 151,087 | 128,198 | 104,151 | 97,866 | 109,977 |
| Depreciation Amortization | 94,881 | 98,170 | 106,197 | 98,897 | 105,240 |
| Income taxes - deferred | 2,689 | 7,060 | -846 | 1,311 | -8,668 |
| Accounts receivable | -16,963 | -28,088 | -19,492 | -16,266 | 7,669 |
| Accounts payable and accrued liabilities | 1,174 | 4,599 | -7,080 | -3,257 | 2,208 |
| Other Working Capital | 28,216 | -3,774 | -25,357 | -25,860 | -27,784 |
| Other Operating Activity | 45,749 | 45,967 | 51,472 | 55,315 | 18,200 |
| Operating Cash Flow | $306,833 | $252,132 | $209,045 | $208,006 | $206,842 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63,252 | -56,925 | -39,154 | -47,534 | -49,143 |
| Net Acquisitions | -247,651 | -234,267 | -29,218 | -16,861 | N/A |
| Purchase Of Investment | -34,235 | -26,648 | -17,566 | -18,537 | -24,556 |
| Sale Of Investment | 19,743 | 21,000 | 11,584 | 25,156 | 31,607 |
| Other Investing Activity | -2,221 | -1,150 | 307 | 2,786 | 5,447 |
| Investing Cash Flow | $-327,616 | $-297,990 | $-74,047 | $-54,990 | $-36,645 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 492,514 | 298,920 | 511,804 | 74,116 | 250,708 |
| Debt Repayment | -417,331 | -194,536 | -523,304 | -140,347 | -252,965 |
| Common Stock Issued | 39,367 | 73,688 | N/A | N/A | N/A |
| Common Stock Repurchased | -117,478 | -122,018 | -165,932 | -64,189 | -283,795 |
| Other Financing Activity | -4,330 | 5,360 | 93,195 | 19,299 | 14,266 |
| Financing Cash Flow | $-7,258 | $61,414 | $-84,237 | $-111,121 | $-271,786 |
| Exchange Rate Effect | -12,695 | -10,379 | -2,613 | -1,009 | -7,107 |
| Beginning Cash Position | 162,575 | 155,927 | 109,685 | 68,905 | 179,160 |
| End Cash Position | 119,963 | 160,023 | 155,927 | 109,685 | 68,905 |
| Net Cash Flow | $-42,612 | $4,096 | $46,242 | $40,780 | $-110,255 |
| Free Cash Flow | |||||
| Operating Cash Flow | 306,833 | 252,132 | 209,045 | 208,006 | 206,842 |
| Capital Expenditure | -63,252 | -56,925 | -39,154 | -47,534 | -49,143 |
| Free Cash Flow | 243,581 | 195,207 | 169,891 | 160,472 | 157,699 |